We are live on
!
Find out more
SEC
Seven Eight Capital Portfolio holdings
AUM
$1.11B
1-Year Est. Return
29.48%
This Fund
S&P 500
This Quarter
Est. Return
+7.98%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$480M
AUM Growth
+$96.7M
(+25%)
Cap. Flow
+$82.2M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
645
New
258
Increased
78
Reduced
78
Closed
231
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$45.7M |
| 2 |
Nasdaq
NDAQ
|
+$5.95M |
| 3 |
Fidelity National Information Services
FIS
|
+$5.66M |
| 4 |
BioMarin Pharmaceuticals
BMRN
|
+$5.09M |
| 5 |
Novartis
NVS
|
+$5.01M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$5.84M |
| 2 |
ExxonMobil
XOM
|
+$5M |
| 3 |
CrowdStrike
CRWD
|
+$4.96M |
| 4 |
British American Tobacco
BTI
|
+$4.57M |
| 5 |
Blackstone
BX
|
+$4.42M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.69% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Healthcare | 14.23% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
BJs Wholesale Club
BJ
$12.4B
| $657K | 0.14% |
+8,632
| New | +$627K |
|
|
PRVB
202
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $656K | 0.14% |
+27,231
| New | +$342K |
|
203
Restaurant Brands International
QSR
$25.3B
| $637K | 0.13% |
9,489
-8,307
| -47% | -$541K |
|
204
Sally Beauty Holdings
SBH
$1.54B
| $635K | 0.13% |
+40,768
| New | +$634K |
|
205
Travelers Companies
TRV
$78B
| $630K | 0.13% |
+3,673
| New | +$668K |
|
206
ChargePoint
CHPT
$143M
| $630K | 0.13% |
3,007
-2,409
| -44% | -$525K |
|
207
Synchrony
SYF
$25.3B
| $625K | 0.13% |
21,495
-18,853
| -47% | -$633K |
|
|
MRTX
208
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $623K | 0.13% |
16,750
-26,514
| -61% | -$1.19M |
|
209
Teva Pharmaceuticals
TEVA
$40.2B
| $620K | 0.13% |
70,109
-1,188
| -2% | -$11.7K |
|
210
Fair Isaac
FICO
$22.6B
| $620K | 0.13% |
+882
| New | +$587K |
|
211
Peabody Energy
BTU
$2.65B
| $619K | 0.13% |
24,177
+3,774
| +18% | +$100K |
|
212
Roper Technologies
ROP
$38.8B
| $601K | 0.13% |
+1,364
| New | +$590K |
|
213
Autodesk
ADSK
$49.6B
| $600K | 0.13% |
2,884
-640
| -18% | -$132K |
|
214
Motorola Solutions
MSI
$72.6B
| $600K | 0.12% |
+2,096
| New | +$553K |
|
215
Jackson Financial
JXN
$8.8B
| $596K | 0.12% |
15,938
-15,877
| -50% | -$652K |
|
216
Gentex
GNTX
$4.99B
| $591K | 0.12% |
+21,090
| New | +$594K |
|
217
Mercado Libre
MELI
$96.3B
| $587K | 0.12% |
+445
| New | +$506K |
|
218
Steris
STE
$22.7B
| $586K | 0.12% |
+3,061
| New | +$592K |
|
219
Bentley Systems
BSY
$10.9B
| $578K | 0.12% |
+13,435
| New | +$534K |
|
220
Huntsman Corp
HUN
$1.76B
| $577K | 0.12% |
+21,090
| New | +$628K |
|
221
EQT Corp
EQT
$33.5B
| $575K | 0.12% |
18,029
-9,455
| -34% | -$303K |
|
222
Vale
VALE
$62B
| $574K | 0.12% |
+36,390
| New | +$616K |
|
223
Beyond Meat
BYND
$316M
| $574K | 0.12% |
+35,374
| New | +$583K |
|
224
Intuitive Surgical
ISRG
$135B
| $568K | 0.12% |
2,223
-1,293
| -37% | -$319K |
|
225
Molson Coors Class B
TAP
$7.86B
| $568K | 0.12% |
10,982
+5,111
| +87% | +$265K |
|
Similar funds
PP
ECM
GCAC
CAM
D
GFS
FTIS
AIA
Seven Eight Capital's Q1 2023 Portfolio in Review
As of Q1 2023, Seven Eight Capital held 645 positions worth $480M, up 25% from $383M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Seven Eight Capital deployed $82.2M of net new capital in Q1 2023, opening 258 new positions and adding to 78 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $5.84M trimmed.
- Seven Eight Capital's largest Q1 2023 buy was State Street SPDR S&P 500 ETF Trust: 114,438 shares worth $46.8M.
- Seven Eight Capital added most to BioMarin Pharmaceuticals in Q1 2023, an estimated $5.09M increase.
- Seven Eight Capital's biggest Q1 2023 reduction was Advanced Micro Devices, cutting an estimated $5.84M.
- Seven Eight Capital fully exited ExxonMobil in Q1 2023, selling an estimated $5M.
- Seven Eight Capital's ten largest holdings make up 20% of its $480M portfolio in Q1 2023.
- Seven Eight Capital opened 258 new positions and closed 231 in Q1 2023.
- Seven Eight Capital's portfolio value rose 25% quarter-over-quarter to $480M.
Based on Seven Eight Capital's 13F filing for Q1 2023, filed 15 May 2023.